DAFTAR PUSTAKA

1. Abdelghani, S. E. A., et al., 2013. Hyperprolactinemia as a cause of female primary

infertility and its prevalence in Gezira State, Central Sudan. Available from :
http://physiology.eajbs.eg.net/pdf/vol5.n1/4.pdf [Accessed on 24th August 2015]
2. Jungare, S., and Vaidya, S., 2013. Hyperprolactinemia and Its Comparison with
Hypothyroidism in Infertile Women. Available from :
https://statperson.com/Journal/ScienceAndTechnology/Article/Volume8Issue2/8_2_12.p
df [Accessed on 24th August 2015]
3. Kumkum, A., Shweta, G., and Ajeshwar, N. P., 2006. Hyperprolactinema and its
correlation with hypothyroidism in infertile women. Available from :
http://medind.nic.in/jaq/t06/i1/jaqt06i1p68.pdf [Accessed on 24th August 2015]
4. Agrawal, M., Samal, S., Hariharan, C., and Agrawal, S., 2013. Prevalence of
hyperprolactinemia in infertile cases and its correlation with TSH in a rural set up
hospital. Available from : http://www.scopemed.org/fulltextpdf.php?mno=45991
[Accessed on 24th August 2015]
5. Binita, G., et. al., 2009. Correlation of Prolactin and Thyroid Hormone Concentration
with Menstrual Patterns in Infertile Women. Available from :
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3719326/pdf/JRI-10-207.pdf [Accessed
on 24th August 2015]
6. Motazedian, S., Babakhani, L., Fereshtehnejad, S. M., and Mojtahedi, K., 2010. A
comparison of bromocriptine & cabergoline on fertility outcome of hyperprolactinemic
infertile women undergoing intrauterine insemination. Available from :
http://www.researchgate.net/publication/44643545_A_comparison_of_bromocriptine__c
abergoline_on_fertility_outcome_of_hyperprolactinemic_infertile_women_undergoing_i
ntrauterine_insemination._Indian_J_Med_Res [Accessed on 24th August 2015]
7. Wang, A. T., et. al., 2012. Treatment of Hyperprolactinemia: A Systematic Review and
Meta-Analysis. Available from :
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483691/pdf/2046-4053-1-33.pdf
[Accessed on 24th August 2015]

1
8. Olooto, W. E., Amballi, A. A., and, Banjo, T. A., 2012. A review of Female Infertility;
important etiological factors and management. Available from :
http://scholarsresearchlibrary.com/JMB-vol2-iss3/JMB-2012-2-3-379-385.pdf [Accessed
on 24th August 2015]
9. Crosignani, P. G., 2012. Management of hyperprolactinemic infertility. Available from :
http://ac.els-cdn.com/S1110569012000349/1-s2.0-S1110569012000349-
main.pdf?_tid=39a6826c-4d5c-11e5-8926-
00000aab0f6b&acdnat=1440749600_87de8329afd9a8e76472b1dccc835a05 [Accessed
on 24th August 2015]
10. JCI, 2012. Hyperprolactinemiainduced ovarian acyclicity is reversed by kisspeptin.
Available from :
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461919/pdf/JCI63937.pd [Accessed on
24th August 2015]
11. Oner, G., 2013. Prolactin and Infertility. Available from :
http://www.intechopen.com/books/prolactin/prolactin-and-infertility [Accessed on 24th
August 2015]
12. Serri, O., Chik, C. L., Ur, E., and Ezzat, S., 2003. Diagnosis and Management of
Hyperprolactinemia. Available from :
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC191295/pdf/20030916s00018p575.pdf
[Accessed on 24th August 2015]
13. Kaiser, U. B., 2012. Hyperprolactinemia and infertility: new insights. Available from :
http://www.jci.org/articles/view/64455/version/2/pdf/rende [Accessed on 24th August
2015]
14. Melmed, S., et. al., 2011. Diagnosis and Treatment of Hyperprolactinemia: An Endocrine
Society Clinical Practice Guideline. Available from :
http://press.endocrine.org/doi/pdf/10.1210/jc.2010-1692 [Accessed on 24th August 2015]
15. Imran, S. A., Ur, E., and Clarke, D. B., 2007. Managing prolactin-secreting adenomas
during pregnancy. Available from :
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1952594/pdf/0530653.pdf [Accessed on
24th August 2015]

2
16. Colao, A., et. al., 2000. Macroprolactinoma shrinkage during cabergoline treatment is
greater in naive patients than in patients pretreated with other dopamine agonists: a
prospective study in 110 patients. Available from :
http://press.endocrine.org/doi/pdf/10.1210/jcem.85.6.6657 [Accessed on 24th August
2015]
17. Corenblum, B., 2009. Bromocriptine Response in Pathological Hyperprolactinemia: A 34
Year Follow-Up of a Homogeneous Population of 827 Patients. Available from :
http://benthamopen.com/contents/pdf/TOEJ/TOEJ-3-38.pdf [Accessed on 24th August
2015]
18. Calao, A., et. al., 2003. Withdrawal of Long-Term Cabergoline Therapy for Tumoral and
Nontumoral Hyperprolactinemia Available from :
http://www.nejm.org/doi/pdf/10.1056/NEJMoa022657 [Accessed on 24th August 2015]